Docstoc

Age Gender Ref Int

Document Sample
Age Gender Ref Int Powered By Docstoc
					The Ohio State University Medical Center                                                 General Reference Intervals
Department of Clinical Laboratories

                        Test                                                       Ref Interval or Notes
Acetaminophen                                       Therapeutic: 10 - 32 ug/mL
Alanine Amino-transferase (ALT/ SGPT)               Male: 10 - 40 U/L; Female: 8 - 25 U/L
Albumin, Quantitative, Serum                        3.4 - 4.8 g/dL
Alcohol, Ethyl                                      0.00 – 0.009 g/dL
Alkaline Phosphatase (Serum)                        Age & Gender specific: see report
Ammonia, Quantitative, Plasma                       11 - 35 umol/L (Venous)
Amikacin                                            Therapeutic: Peak: 15-30 ug/mL; Trough: less than 8 ug/mL
Amylase, Serum                                      28 - 100 U/L
Amylase, Urine                                      0-400 U/24 Hrs.
Aspartate Aminotransferase (AST/SGOT)               5 - 34 U/L
B12 Vitamin                                         211 – 911 pg/mL
Bilirubin, Total and Direct or Conjugated           Total Bilirubin: less than 1.5 mg/dL; Conj. Bilirubin: less than 0.3 mg/dL
Blood Urea Nitrogen                                 6.0 – 20.0 mg/dL
Calcium, (Urine)                                    100 – 300 mg/24 Hrs.
Calcium, Ionized                                    4.6 - 5.3 mg/dL
Calcium, Total (Serum)                              8.6 - 10.0 mg/dL
Carbamazapine (Tegretol®)                           Therapeutic: 4.0 – 12.0 ug/mL
Carboxy-hemoglobin                                  0.0 – 5.0%
Chloride (Serum)                                    98 - 107 mmol/L
Chloride (Urine)                                    110 - 250 mmol/24 Hrs.
Cholesterol, High Density Lipoprotein               High risk: less than40 mg/dL; Low Risk: 60mg/dL
Cholesterol, Total                                  Desirable: less than 200 mg/dL; Borderline High: 200-239 mg/dL; High risk:
                                                    greater than 239
                                                    mg/dL
CO2, Total (Serum)                                  21 - 31 mmol/L
Complete Blood Count                                MALE: WBC: 4.5-11.0 K/uL, RBC: 4.3-5.7 M/uL, Hgb: 13.2-17.3 g/dL, Hct:
                                                    39.0-49.0 %, MCV: 80.0-99.0 fL. FEMALE: WBC: 4.5-11.0 K/uL, RBC: 3.8-5.1
                                                    M/uL, Hgb: 11.7-15.5 g/dL, Hct: 35.0-45.0%, MCV: 81.0-100.0. ALL: Platelet
                                                    150 – 400 K/uL; MCHC: 32-36 g/dL; RDW: 11.6-14.8
Cortisol                                            Normal established for 8 AM: 3.09 - 22.40 ug/dL
CPK                                                 Male: 37 - 174 U/L; Female: 26 - 140
Creatine Kinase, Total                              Male: 37 - 174 U/L; Female: 26 - 140
Creatinine (Serum)                                  Male: 0.9 - 1.3; Female: 0.6 - 1.1 mg/dL
Creatinine (Urine)                                  Male: 0.8 - 2.0; Female: 0.6 - 1.8 g/24 hrs
Crystals (Synovial Fluid)                           Absent
CSF Glucose                                         40 - 70 mg/dL
Cyclosporine Blood Level, CSA                       100-400 ng / mL
Differential, Electronic                            GRANS / SEGS: 40-70%, LYM: 22.0-44.0%, MONO: 0-7.0%, EOS: 0-5.0%,
                                                    BASO: 0-2.0%;

                                                    ABSOLUTE GRANS / SEGS: 1.8-7.7 K/uL, LYM: 1.0-4.8 K/uL, MONO: 0-0.8
                                                    K/uL, EOS: 0-0.5 K/uL, BASO: 0-0.2 K/uL
Digoxin (Lanoxin®)                                  Therapeutic: CHF: 0.5 – 1 ng/mL
Dilantin® Phenytoin                                 Therapeutic: 10.0 – 20.0 ug/mL
Eosinophil Count                                    0.0-0.5 K / uL
Ethanol (Blood)                                     0.00 – 0.009 g/dL
Ferritin                                            MALE: 22 - 322 ng/mL; FEMALE: 10 - 291 ng/mL
Fetal Fibronectin                                   Negative
Folate - Serum                                      greater than 5.38 ng/mL
Follicle Stimulating Hormone, (Serum)               Adult Male: less than 18.1 mIU/mL; Adult Female: Follicular: 2.5 - 10.2
                                                    mIU/mL, Midcycle: 3.4 - 33.4 mIU/mL, Luteal 1.5- 9.1 mIU/mL, Pregnant: less
                                                    than 0.3 mIU/mL, Postmenopausal: 23.0 -116.3 mIU/mL
Free T3                                             2.3 - 4.2 pg/mL

              (original in Lab Administration)   Medical Director Review   Amy S. Gewirtz, MD                  Date:   7/12/10




e0de2ba1-4289-46af-a3e0-46ab2288d2d2.doc Page 1 of 5                                              7/7/2010
The Ohio State University Medical Center                                               General Reference Intervals
Department of Clinical Laboratories



                   Test                                                     Ref Interval or Notes
Free T4                                        0.89 - 1.76 ng/dL
Gamma Glutamyl Transferase                     8 - 64 U/L
Garamycin®                                     Therapeutic: Peak 5 -10 ug/mL; Cystic Fibrosis: 10-12 ug/mL;
                                               Trough less than 2 ug/mL
Gases                                          Specify O2 % or liter flow and ventilator settings (if applicable) on request form.
                                               Reference intervals are age & gender specific - see report.
Gentamicin (Garamycin®)                        Therapeutic: Peak 5.0 -10.0 ug/mL; Cystic Fibrosis: 10.0-12.0 ug/mL;
                                               Trough less than 2.0 ug/mL
Glucose (Serum)                                74 - 106 mg/dL
Glucose (Urine)                                less than 0.5 g/24 Hrs.
HCT                                            MALE: 39.0-49.0%; FEMALE: 35.0-45.0%
HDL Cholesterol                                High risk: less than 40 mg/dL; Low Risk: 60 mg/dL
Hematocrit                                     MALE: 39.0-49.0%; FEMALE: 35.0-45.0%
Hemoglobin                                     MALE: 13.2-17.3 g/dL; FEMALE: 11.7-15.5 g/dL
HGB                                            MALE: 13.2-17.3 g/dL; FEMALE: 11.7-15.5 g/dL
Human Chorionic Gonadotropin, Quantitation     Non-Pregnant: less than 5 mIU/mL; 0.2 – 1 week: 5 – 50; 1-2 weeks: 50 – 100;
(Serum) UPDATED                                2-3 weeks: 100 – 5000; 3-4 weeks: 500 – 10,000; 4-5 weeks: 1000 – 50,000;
                                               5-6 weeks: 10,000 – 100,000; 6-8 weeks: 15,000 – 200,000; 8-12 weeks:
                                               10,000 – 100,000; Male: less than 5 mIU/mL
Intact PTH                                     14.0 – 72.0 pg/mL
Iron Saturation                                20 - 55%
Iron, Total (Serum)                            Males: 65 - 175 ug/dL; Females: 50 - 170 ug/dL
Lactic Acid                                    0.7 - 2.5 mmol/L
LD (Lactate Dehydrogenase)                     100 - 190 U/L
Lipase                                         18 - 51 U/L
Lithium                                        Therapeutic Range: 0.6 - 1.2 mmol/L, acute mania: 1.2 - 1.5 mmol/L
Low Density Lipoproteins                       Optimal: less than100 mg/dL Near Optimal: 1-129 mg/dL; Borderline High: 130-
                                               159 mg/dL; High:160-189 mg/dL; Very High: greater than190 mg/dL
Magnesium (Serum)                              1.6 - 2.6 mg/dL
Magnesium (Urine)                              72.9 - 121.5 mg/24 Hrs.
Methemoglobin                                  Less than 1.3 %
Mono Test Rapid                                Normal is negative
Myoglobin, Qualitative (Urine)                 Normal is negative
Occult Blood Gastric                           Normal is negative; Method: Gastroccult
Occult Blood Stool (Guiac)                     Normal is negative; Method: Hemoccult
Oral Glucose Tolerance: Adult (non-pregnant)   Fasting: <100 mg/dL; 120 min: <140 mg/dL
Oral Glucose Tolerance: Adult (pregnant)       Fasting: 95 mg/dL; 60 min: 180 mg/dL; 120 min: 155 mg/dL; 140 min: 180
                                               mg/dL
Osmolality (Serum)                             275-295 mOsm/kg
Osmolality (Urine)                             300-900 mOsm/kg
Partial Thromboplastin Time (APTT)             Reference: 24 – 35 sec; Heparin Therapy, Therapeutic: (For treatment of acute
                                               thrombosis): 68 - 100 sec; Method: STA American Bioproducts (Clottable
                                               assay)
Phenobarbital                                  Therapeutic: 15 - 40 ug/mL
Phenytoin                                      Therapeutic: 10.0-20.0 ug/mL
Phosphorus, Inorganic (Serum)                  2.7 - 4.5 mg/dL
Phosphorus, Inorganic (Urine)                  0.4 - 1.3 g/24 Hrs.
Platelet Count                                 Platelet 150 - 400 K/uL; MPV 7.5 - 11.2 fL
Potassium, Serum                               3.5 - 5.1 mmol/L
Potassium, Urine                               25 - 125 mmol/24 Hrs.
Protein, Total (Urine)                         40-225 mg/24 Hrs.




e0de2ba1-4289-46af-a3e0-46ab2288d2d2.doc Page 2 of 5                                            7/7/2010
The Ohio State University Medical Center                                             General Reference Intervals
Department of Clinical Laboratories



                     Test                                                   Ref Interval or Notes
Prothrombin Time & INR (International          PT: 12.8 - 14.9 sec; INR: Therapeutic range for standard therapy: 2.0-3.0;
Normalized Ratio)                              Therapeutic range for high dose therapy: 2.5-3.5; Method: STA American
                                               Bioproducts (Clotting assay)
Reticulocyte Count                             Corrected: 0.5 - 1.5%; Absolute: 0.024 - 0.084 M/uL
Salicylate (Aspirin)                           Therapeutic: 20 - 30 mg/dL
Sedimentation Rate, Erythrocyte (Westergren)   Male: 0 - 29; Female: 0 - 41 mm/hr
Sodium (Urine)                                 40 - 220 mmol/24 Hrs.
Sodium, Serum                                  136 - 145 mmol/L
Specific Gravity (Urine)                       1.003-1.035
T3, Free                                       2.3 - 4.2 pg/mL
T Uptake                                       0.75 - 1.23 Binding Index
T4                                             4.5 - 10.9 ug/dL
T4, Free                                       0.89 - 1.76 ng/dL
Theophylline (aminophylline)                   Therapeutic: bronchodilator: 10 - 20 ug/mL; Neonatal apnea: 6 - 13 ug/mL
Thyroid Stimulating Hormone - 3rd Generation   0.550 – 4.780 uIU/mL
TIBC                                           298 - 596 ug/dL
Tobramycin                                     Therapeutic: Peak: 5.0 – 10.0 ug/mL; Trough: less than 2.0 ug/mL
Total Protein, Serum                           6.4 - 8.3 g/dL
Transferrin                                    200 - 400 mg/dL
Triglycerides                                  Desirable: < 150 mg/dL; Borderline: 150 - 199 mg/dL; High: 200 - 499 mg/dL;
                                               Very High: > 500 mg/dL
Troponin-I                                     Normal: less than 0.11 ng/mL
Urea Nitrogen (Urine)                          12 - 20 g/24 Hrs
Uric Acid (Serum)                              Male: 4.4 - 7.6 mg/dL; Female: 2.3 - 6.6 mg/dL
Uric Acid (Urine)                              0.25 - 0.75 g/24 Hrs.
Urinalysis                                     SPGR: 1.003-1.035; UGL: Negative; UBIL: Negative: UKET: Negative;
                                               UBLD: Negative; UPH: 5.0-7.0; UPR: Negative; UNTR: Negative; ULEU:
                                               Negative; UWBC: 0-5; URBC: 0-2; BACT: Absent ; Color: Yellow and Dark
                                               Yellow; Clarity: Clear
Valproic Acid                                  Therapeutic: 5 - 120 ug/mL
Vancomycin                                     Therapeutic: Peak: 20 - 40 ug/mL; Trough: 10 - 20 ug/mL
Watson Schwartz Test (Urobilinogen,            Normal is negative
Porphobilinogen Screen)
White Cell Count                               4.5-11.0 K/u L




e0de2ba1-4289-46af-a3e0-46ab2288d2d2.doc Page 3 of 5                                          7/7/2010
The Ohio State University Medical Center                                                  General Reference Intervals
Department of Clinical Laboratories



                                   Age / Gender Specific Reference Intervals

                   Test                      Age                Male             Female                 Units
         Alkaline Phosphatase       greater than 19        38-126             38-126              U/L
                                    16 - 18                52-171             47-119              U/L
                                    13 - 15                74-390             50-162              U/L
                                    10 - 12                42-362             51-332              U/L
                                    7-9                    86-315             69-325              U/L
                                    4-6                    93-309             96-297              U/L
                                    1-3                    104-345            108-317             U/L
                                    greater than 1 month   82-383             124-341             U/L
                                    Newborn                75-316             48-406              U/L

         PH, blood gas              Newborn                              7.29-7.45
                                    greater than 1 month                 7.35-7.45

         PCO2, blood gas            Newborn                               27-40                   mmHg
                                    greater than 1 month                  32-48                   mmHg

         Bicarbonate (HCO3),        Newborn                               17-24                   mmol/L
         blood gas                  greater than 1 month                  22-26                   mmol/L

         O2 Saturation              Newborn                               40-90                   %
                                    greater than 1 year                   94-98                   %

         Hematocrit                                        39.0 - 49.0        35.0 - 45.0         %

         Hemoglobin                                        13.2 - 17.3         11.7 - 15.5        g/dL

         MCV                                               80.0 - 99.0        81.0 - 100.0        fL

         Red Blood Cell Count                              4.3 - 5.7          3.8 - 5.1           M/uL

         Insulin Growth Factor 1    1 yr                                  55 – 327                ng/mL
                                    2                                     51 – 303                ng/mL
                                    3                                     49 – 289                ng/mL
                                    4                                     49 – 283                ng/mL
                                    5                                     50 – 286                ng/mL
                                    6                                     52 – 297                ng/mL
                                    7                                     57 – 316                ng/mL
                                    8                                     64 – 345                ng/mL
                                    9                                     74 – 388                ng/mL
                                    10                                    88 – 452                ng/mL
                                    11                                   111 – 551                ng/mL
                                    12                                   143 – 693                ng/mL
                                    13                                   183 – 850                ng/mL
                                    14                                   220 – 972                ng/mL
                                    15                                   237 – 996                ng/mL
                                    16                                   226 – 903                ng/mL
                                    17                                   193 – 731                ng/mL
                                    18                                   163 – 584                ng/mL



e0de2ba1-4289-46af-a3e0-46ab2288d2d2.doc Page 4 of 5                                              7/7/2010
The Ohio State University Medical Center                                      General Reference Intervals
Department of Clinical Laboratories


                    Test                        Age    Male               Female          Units
         Insulin Growth Factor 1 -   19                       141 – 483               ng/mL
         continued                   20                       127 – 424               ng/mL
                                      21 - 25                 116 – 358               ng/mL
                                      26 - 30                 117 – 329               ng/mL
                                      31 - 35                 115 – 307               ng/mL
                                      36 - 40                 109 – 284               ng/mL
                                      41 - 45                 101 – 267               ng/mL
                                      46 - 50                  94 – 252               ng/mL
                                      51 - 55                  87 – 238               ng/mL
                                      56 - 60                  81 – 225               ng/mL
                                      61 - 65                  75 – 212               ng/mL
                                      66 - 70                  69 – 200               ng/mL
                                      71 - 75                  64 – 188               ng/mL
                                      76 - 80                  59 – 177               ng/mL
                                      81 - 85                  55 – 166               ng/mL




e0de2ba1-4289-46af-a3e0-46ab2288d2d2.doc Page 5 of 5                                  7/7/2010